Older Adults and Mental-Health Medicines: Benefits, Falls and Medication Review

Depression, anxiety, bipolar disorder and psychosis deserve appropriate treatment in older adults. Reviewing a regimen should not mean dismissing symptoms as inevitable aging or withdrawing effective care simply because a person has reached a particular birthday. The question is whether each medicine still has a clear purpose and an acceptable balance of benefit and harm.

The US National Institute on Aging recommends discussing all prescriptions, non-prescription medicines and supplements with the treating team. Multiple conditions and medicines can increase the complexity of care. A complete list is more useful than reviewing the psychiatric prescription in isolation. [1]

Changes in physical health, medicine handling and other treatment can alter the effects of an established regimen. A familiar medicine is not automatically harmless because it has been taken for years. Equally, a new symptom is not automatically caused by that medicine. A review should examine the timeline and the whole clinical picture.

Tell the clinician about changes in weight, appetite, mobility, sleep, memory and ability to manage everyday tasks. Include recent hospital admissions and newly prescribed short courses, such as antibiotics or pain treatment. These details may explain why a previously workable plan has become difficult. The FDA emphasizes that medicine regimens may need adjustment later in life. [2]

Psychotropic medicines can contribute to falls risk. NICE’s falls guideline recommends structured medication review and discussion of that risk, with changes or withdrawal planned where appropriate and specialist mental-health input when needed. This is not a recommendation for every older person to stop psychiatric medication. [3]

Describe the circumstances of a fall: getting out of bed, walking to the bathroom, a recent dose change or feeling faint before falling. Mention alcohol, dehydration and other medicines. Assessment should consider vision, balance, blood pressure and the home environment as well as prescribing. A single-cause explanation can miss other treatable risks.

Benzodiazepines, sleep medicines, some antidepressants, antipsychotics and other treatments can affect alertness. Several modestly sedating products may create a substantial combined problem. Non-prescription sleep or allergy remedies also belong in the list. Do not assume that a product purchased at a pharmacy counter is irrelevant to daytime drowsiness.

Report sleeping through meals, difficulty waking, reduced participation in activities or new problems with driving. A family member may notice a change, but the person’s own experience should remain central. The goal is not simply to make someone quieter. Treatment should support meaningful functioning and comfort without avoidable impairment.

Some medicines have anticholinergic effects that can contribute to dry mouth, constipation, blurred vision, urinary difficulty or cognitive problems. The cumulative effect of several medicines can matter. NICE dementia guidance recommends considering and minimizing medicines associated with anticholinergic burden where appropriate, rather than treating each prescription as an isolated decision. [4]

These symptoms should not automatically be accepted as aging. Explain when they began and what changed in treatment. A pharmacist or clinician can review whether a medicine may contribute, whether another cause needs investigation and whether an alternative is suitable. Do not use a simple online burden score as a personal instruction to discontinue treatment.

Sudden confusion can be a medical emergency. It may have several causes, including acute illness, low blood sugar, medicines or other problems. NHS advice is to obtain urgent medical help rather than assume the change is dementia. A person may need prompt assessment even when they already have a memory disorder. [5]

Tell the team what the person is normally like and how quickly the change occurred. Bring recent medicine changes, actual use and relevant health information. Do not give extra sedatives to settle unexplained confusion. A quiet or withdrawn presentation can also be important; the absence of agitation does not establish that the person is well.

Antipsychotics are not routine solutions for every expression of distress in dementia. NICE recommends assessing causes of distress and discussing benefits and harms before treatment. When an antipsychotic is appropriate, the indication, duration and review arrangements should be explicit. Lewy body and Parkinson’s disease dementia need particular caution because sensitivity reactions can occur. [4]

Regulatory guidance identifies increased stroke and mortality risks when antipsychotics are used in older people with dementia. The authorized indications vary by product and country. A prescription for longstanding schizophrenia or bipolar disorder is a different clinical context and should not be conflated with treatment of dementia-related behavior. [6]

Kidney function can influence the exposure to some psychiatric and neurological medicines. The appropriate calculation and interpretation depend on the product and the person; a single laboratory number is not always enough. Changes in muscle mass, hydration or acute illness can complicate estimates. A clinician should assess trends and the full context. [7]

Ask which medicines depend particularly on kidney function and whether recent results are available. Report vomiting, diarrhea, reduced fluid intake or a new illness promptly when taking a medicine with a narrow safety margin. Do not use a general kidney-stage table to calculate a personal dose adjustment.

Lithium requires blood-level and physical-health monitoring, including kidney and thyroid function. Older age, interacting medicines and changes in fluid or salt intake may justify more frequent checks. New tremor, unsteadiness, vomiting, diarrhea or mental-state changes can be warning signs of toxicity. [8]

Suspected lithium toxicity requires urgent medical advice and withholding further lithium while assessment is obtained. This is different from a routine plan to reduce treatment. Make sure the person and any agreed carer know the specific safety instructions, the correct brand or formulation and which service is responsible for interpreting blood results.

A medication review should include whether the original condition remains active. Ask about mood, worry, interest, sleep, isolation and functioning without assuming that all changes result from physical illness. Psychological treatment and practical support may complement prescribing, but should not be offered as a reason to ignore severe psychiatric symptoms.

When a medicine appears ineffective, consider actual use, tolerability and the treatment goal before changing it. Hearing, vision, language and memory difficulties may make instructions harder to follow. A simpler, better explained plan may be more useful than adding another medicine to an already confusing regimen.

Long-term benzodiazepines, Z-drugs and gabapentinoids require attention to dependence and withdrawal, while antidepressants can also cause withdrawal symptoms. A fall or concern about sedation may justify review, but does not make abrupt cessation safe. An individualized reduction should consider the medicine, duration, previous experience and the underlying condition.

The 2026 MHRA warning update emphasizes dependence, addiction, tolerance and withdrawal risks for several of these groups. Physical dependence should not be mistaken automatically for addiction, and neither should be managed through blame. A clear plan and accessible follow-up are especially important when the person relies on others to organize medication. [9]

Ask about alcohol and other substances respectfully, without assuming they are irrelevant in later life. Opioid pain treatment, sleeping tablets and sedating medicines can interact. Products for coughs, pain and sleep may also contain overlapping ingredients. The pharmacist needs actual use, including occasional products, to assess the combined regimen.

A person should not take a relative’s medicine or restart old supplies because a familiar symptom returns. Keep current and discontinued prescriptions clearly separated, and ask about safe disposal. The interaction-review guide provides a structured way to prepare the complete list.

Discuss whether labels are readable, containers can be opened and the person understands what as-needed treatment means. Consider reminders, suitable packaging or an agreed support person where useful. Do not assume a pill organizer is appropriate for every product; a pharmacist should check storage and packaging requirements.

Involve relatives or carers with the person’s agreement and according to the relevant care arrangements. The person should still be asked about preferences, benefits and adverse effects. A quieter household is not the same outcome as improved well-being. Support should make the treatment easier to manage, not replace the patient’s voice.

After a hospital stay, reconcile the new list with the previous one. Clarify which medicines were started temporarily, which were stopped and who will review them. A prescription added during an acute illness should not continue indefinitely simply because it appears on a discharge summary without an end plan.

Ask the receiving service to confirm responsibility for supplies, tests and follow-up. Keep the reasons for changes visible, not only the names and doses. This helps avoid duplication and prevents an old prescription being restarted without understanding why it was discontinued. A clear handover also reduces the burden on family members trying to interpret conflicting instructions.

Bring the actual medicines and a short description of the main concerns. Choose practical priorities such as fewer falls, better daytime alertness, improved mood or an easier regimen. Ask which medicines provide a current benefit, which may contribute to the problem and what monitoring or changes are proposed.

Confirm the next step in writing, including who will assess the outcome and when. A review may lead to maintaining treatment, changing one medicine or arranging further assessment. It should not be judged by the number of prescriptions removed. The aim is safer, effective and understandable care that fits the person’s life.

Are psychiatric medicines always inappropriate in older adults?

No. They can be important and effective. The indication, individual response, physical health, interactions and monitoring determine suitability.

Should a medicine be stopped after a fall?

A fall is a reason for assessment and medication review, not an automatic instruction to stop. Some medicines need a gradual, supported change and the fall may have several causes.

What needs urgent help?

Sudden confusion, stroke symptoms, collapse, a seizure, serious breathing difficulty or immediate suicidal danger requires urgent medical assessment. Do not assume these are normal aging or expected side effects.

• [1] National Institute on Aging: Taking medicines safely as you age.
• [2] FDA: Medication safety tips for older adults.
• [3] NICE NG249: Falls assessment and prevention.
• [4] NICE NG97: Dementia assessment and management.
• [5] NHS: Sudden confusion.
• [6] MHRA: Antipsychotic medicines.
• [7] NHS Specialist Pharmacy Service: Calculating kidney function.
• [8] NHS Specialist Pharmacy Service: Lithium monitoring.
• [9] MHRA: Dependence and addiction warning update, January 2026.